Yeah. Well, interesting. And over the last year or so, Siemens has introduced four priorities. I mean, it’s just this simple, right? We’ve got to have customer impact. We develop technology with purpose. You know, this is our why.
And then you go, well, how are we going to get there? Well, empowerment, you know, I chatted with you about the idea that local leaders everywhere really are part of a network as opposed to a hierarchy. But maybe the most fundamental priority is cultivating a growth mindset. And I know in your path, you’ve touched on this in so many ways. A growth mindset that a person’s belief that they can learn new things, do new things and become different and actually fit into an ever-changing future.
So, what we’re finding is that if we can actually work with folks to appreciate what we’re calling the durable skills that go along with the technical, hard skills that we’ve referred to in the past, we can get people confident in the fact that they can adapt to an ever-changing world.
Now, this is happening not only inside Siemens, but with our customers. And a great example is the work we’ve done with the FDA. Think about the challenge the FDA has had as, you know, we’ve got a world demanding all kinds of new first, you know, therapeutics, detection, treatments, etc. And what we’ve been able to do working with them is introduce new digital tools.
So, the FDA is actually disrupting their own business process to say, hey, we can use digitalization now to allow us to see virtual, a digital twin of a new proposed production process. We can actually go through a lot of steps of approval digitally without ever having to visit a site or exchange massive documentation. And we can shorten the cycle time for bringing innovations into the marketplace.
It’s this kind of possibility that we’re just trying to tell the stories everywhere we can so that people in different fields can see, ah, if NASA could use this technology to create a rover that landed on the surface of Mars and the FDA can use it to do drug approvals or new medical device approvals, how could we be using this same technology in our own world? And it’s happening everywhere.
